Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging is poised for success with its integrated healthcare platform, established procurement relationships, and a growing distribution network. The recently announced partnership with Imperial Imaging Technology in the Southeast region is a significant step towards wider adoption of their Nanox.ARC system and improving commercial capabilities, with potential for further agreements and increased utilization driving revenue growth. However, execution risks and the need for additional financing remain key factors to monitor.

Bears say

Nano X Imaging is facing significant risk factors in terms of clinical/regulatory, partnership and financial, commercial, legal and intellectual property, and market share risks, which could impede the success of its Nanox.ARC segment. While the company is strategically targeting lower-cost and lower-radiation alternatives to traditional CT, its success will depend on system placements, utilization rates, and reimbursement dynamics. Upcoming catalysts to monitor include system rollouts, distributor agreements, and utilization trends, as well as updates on FDA interactions and financing activity.

Nano-X Imaging (NNOX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Nano-X Imaging (NNOX) has a Strong Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.